ALB and Hurler syndrome: Previous studies have demonstrated the expression of therapeutic transgenes from the albumin locus in the liver;7 here, we test the therapeutic benefit of inserting a human IDUA (hIDUA) transgene at the albumin locus in hepatocytes using the murine model of Hurler syndrome.12